patients who took an inhaled corticosteroid each day, researchers found that their risk of developing cataracts was 24 percent higher than patients who did not use the drugs.
Researchers also noted an increase in patients who took half the typical daily dose of a prescribed inhaled corticosteroid. Of all the patients studied, over 10,000 of them developed severe cataracts.
If patients are prescribed an inhaled corticosteroid, study author Dr. Samy Suissa, an epidemiologist at McGill University Health Centre in Montreal, recommend a long-acting bronchodilator or anti-leukotriene combination therapy to reduce the risk of cataracts.
The study findings appear in the June issue of the European Respiratory Journal.